Freespira® Study Shows 80% Panic Attack Reduction Rate

Palo Alto Health Sciences, Inc. (PAHS) has completed a study on one-year results of their Freespira® at-home treatment for panic attack disorder. The multi-center clinical trial showed that nearly 80% of patients treated with Freespira® remain free of panic attacks after one year.

Treatment with Freespira® requires only two 17-minute respiratory treatment sessions a day over a four-week period. The 12-month study confirms results from a prior, single-academic center study.

PAHS is a digital therapeutic company focused on revolutionizing the mental health industry with clinically proven, non-invasive, drug-free solutions.

This was . . .